SCHEMBL7345240

SCHEMBL7345240

NN=Cc1ccc2cc(C(=O)Nc3ccc(CO)cc3)ccc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 8/20 0.64
PLG P00747 5/20 0.64
KLKB1 P03952 5/20 0.64
PRSS1 P07477 5/20 0.64
PLAT P00750 4/20 0.64
F2 P00734 4/20 0.64
NR1H4 Q96RI1 2/20 0.49
DEGS1 O15121 1/20 0.45
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.44
NAMPT P43490 1/20 0.44
KLK1 P06870 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
CASP3 P42574 1/20 0.42
SENP7 Q9BQF6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7343081 0.90 PLAU (0.67) PLAUPLGKLKB1PRSS1PLAT
SCHEMBL7343089 0.90 PLAU (0.67) PLAUPLGKLKB1PRSS1PLAT
SCHEMBL7345579 0.89 PLAU (0.65) PLAUPLGKLKB1PRSS1PLAT
SCHEMBL7340329 0.86 PLAU (0.63) PLAUPLGKLKB1PRSS1PLAT
SCHEMBL7336457 0.85 NPC1 (0.53) PLAUPLGKLKB1PRSS1PLAT
Trifluoroacetic Acid SCHEMBL7344126 0.83 PLAU (0.58) PLAUPLGKLKB1PRSS1PLAT
Trifluoroacetic Acid SCHEMBL7344120 0.83 PLAU (0.58) PLAUPLGKLKB1PRSS1PLAT
SCHEMBL27570130 0.83 PLAU (0.56) PLAUPLGKLKB1PRSS1PLAT
SCHEMBL7335937 0.82 DEGS1 (0.57) NR1H4DEGS1NPC1RAB9AKMT2A
SCHEMBL7337258 0.81 IKBKB (0.56) PLAUPLGPLATNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 US claimed
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 US disclosed
US-6258822-B1 ENZYME INHIBITORS OF NAPHTHALENE AMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 PLAU 2/4885PLG 10/4885KLKB1 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.